Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-006823

Global President TAVR & Surg sold 8,660 shares at an average $90.15 ($780,681)

  • Global President TAVR & Surg acquired 8,660 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wood Larry L · Global President TAVR & Surg

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-14 Exercise or conversion : show line 1 in the form 10b5-1 +8,660 $45.28 $392,096 222,453.71 D
2023-06-14 Sale : show line 2 in the form 10b5-1 −2,850 $90.71 $258,528 219,603.71 D
2023-06-14 Sale : show line 3 in the form 10b5-1 −5,810 $89.87 $522,152 213,793.71 D
Open-market sales · 8,660 sh · avg $90.15 · $780,681

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-06-14 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −8,660 $45.28 2025-05-16 8,660 49,719 D
Loading xslF345X04/doc4.xml…